2019 - 2022 Elucidation of molecular mechanism of ferroptosis and construction of new therapeutic strategy in renal cell carcinoma
2018 - 2021 Elucidation of the pathophysiology of interstitial cystitis by immunological profiling and development of novel diagnostic tools and treatment methods
2018 - 2021 analysis of the effect of changes in the microenvironment around cancer on renal cancer stem cells: development of new treatment strategies
2020 - 山田養蜂場 特定臨床研究 共同研究助成
2016 - 2019 A novel predicitve model of urinary tract recurrence in urothelial cancer by comprehensive analyses of urine immunocomplex
2013 - 2016 Chemoprevention of prostate cancer using inhibition of PGE2 receptors and HuR suppression by green tea polyphenol
2011 - 2014 Analysis of anoikis resistance acquisition, and studies of prognostic predictor and therapeutic target in renal cell carcinoma
Show all
Papers (345)：
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, et al. Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950). 2024. 213. 1. 23-28
Shintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, Kyohei Araki, Kensuke Mitsunari, Kojiro Ohba, Yasushi Mochizuki, Ryoichi Imamura. Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reports. IJU case reports. 2024. 7. 4. 324-328
Kensuke Mitsunari, Hajime Fukushima, Hiroki Kurata, Junki Harada, Yuichiro Nakamura, Tomohiro Matsuo, Kojiro Ohba, Yasushi Mochizuki, Ryoichi Imamura. Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy: The Impact of PSA Level, Gleason Score, and Pathological Tumor Stage. Anticancer research. 2024. 44. 7. 3149-3154
Robot-assisted radical nephrectomy with inferior vena cava tumor thrombectomy for renal cell carcinoma with inferior vena cava tumor thrombus
(The 111th Annual Meeting of the Japanese Urological Association 2024)
Japanese prospective registry of nivolumab plus ipilimumab in first-line metastatic renal cell carcinoma (J-ENCORE study): result from 4th interim analysis
(The 111th Annual Meeting of the Japanese Urological Association 2024)
2001 - 2005 Nagasaki University Graduate School of Biomedical Sciences
1992 - 1998 Nagasaki University School of Medicine
Work history (5)：
2023/02 - 現在 長崎大学大学院医歯薬学総合研究科 泌尿器科学 准教授
2021/02 - 現在 Nagasaki University Hospital Department of Urology and Renal Transplantation
2015/04 - 現在 Nagasaki University Hospital
2010/06 - 2015/03 Nagasaki University Hospital
1998/04 - 2000/03 Nagasaki University
Committee career (8)：
2024/04 - 現在 泌尿器科分子・細胞研究会 評議員
2023/04 - 現在 西日本泌尿器科 査読委員
2023/03 - 現在 九州泌尿器科連合地方会 理事
2020/08 - 現在 腎癌研究会 学術評議員
2019/08 - 現在 日本泌尿器内視鏡学会 日本泌尿器内視鏡学会会誌査読委員
2019/04 - 現在 日本癌治療学会 日本癌治療学会会誌査読委員
2018/04 - 現在 西日本泌尿器科学会 評議員
2016/05 - 現在 日本泌尿器内視鏡学会 代議員
Show all
Awards (6)：
2024/02 - International Journal of Urology reviewers of the year in 2023
2023/07 - 一般社団法人 輔仁会 若手教育研究者のための助成金
2022/02 - International Journal of Urology International Journal of Urology reviewers of the year in 2021
2018/05 - American Urological Association Best posters award
2015/04 - 長崎県医師会 医学研究助成
2005/11 - 日本泌尿器科学会西日本総会 ヤングウロロジストリサーチコンテスト奨励賞
Show all
Association Membership(s) (9)：
日本小児泌尿器科学会
, Japanese society for clinical renal transplantation
, 腎癌研究会
, The west Japan urological association
, 日本内視鏡外科学会
, 日本がん治療学会
, Japanese Society for Dialysis Therapy
, JAPANESE SOCIETY OF ENDOUROLOGY
, THE JAPANESE UROLOGICAL ASSOCIATION
